Blog
Gene therapies – simpler doesn’t mean simple
Blog
Cell and gene therapies are produced and delivered via the most complex workflows in the history of medicine. Among those workflows, though, there’s a range…
Vineti secures new patent from USPTO for individualized medicine platform
Blog
SAN FRANCISCO, March ##, 2022 (GLOBE NEWSWIRE) – Vineti, Inc., the provider of the leading digital platform of record for cell and gene therapies, today…
Cell and gene therapies – new treatments, new value
Blog
At the recent Gene Therapy for Rare Disorders conference in Boston, I had the opportunity to discuss thoughts on value with an audience dedicated to…
Vineti Appoints Ann Klein as Chief Executive Officer
Blog
Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the successful completion of its Service Organization Control (SOC®)…